Detalhe da pesquisa
1.
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Lancet Oncol
; 18(6): 803-811, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434660
2.
Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.
JAMA Oncol
; 9(3): 365-373, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633877
3.
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial.
Int J Radiat Oncol Biol Phys
; 115(1): 142-152, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007724
4.
A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes.
Cancers (Basel)
; 14(4)2022 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205686
5.
Interfractional Geometric Variations and Dosimetric Benefits of Stereotactic MRI Guided Online Adaptive Radiotherapy (SMART) of Prostate Bed after Radical Prostatectomy: Post-Hoc Analysis of a Phase II Trial.
Cancers (Basel)
; 13(11)2021 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34199881
6.
Patient perspectives and treatment regret after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal cancer: Findings from a phase II trial.
Head Neck
; 41(8): 2768-2776, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30958605